Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group

Author(s):
Sluis, I.M. van der; Groot-Kruseman, H. de; Loo, M. te; Tissing, W.J.E.; Bos, C. van den; Kaspers, G.J.L.; Bierings, M.; Kollen, W.J.W.; Konig, T.; Pichlmeier, U.; Kuhnel, H.J.; Pieters, R.
Published
2018
Publication type
Article / Letter to editor
efficacypediatric acute lymphoblastic leukemiarandomized trialrecombinant asparaginasetoxicity
Date issued
2018-08-31
Language
English
Is part of
Pediatric Blood & Cancer (2018), No. 8
hdl
1887/95864
doi
10.1002/pbc.27083